| Michael F. Mahoney |
Michael F. Mahoney is currently the Chairman, President & Chief Executive Officer at Boston Scientific Corp. He is also the Chief Executive Officer at EndoChoice, Inc., Boston Scientific Scimed, Inc., CEO Roundtable LLC, and Vertiflex, Inc. Additionally, he serves as the Member-CEO Roundatable at the American Heart Association, Inc. and Chairman-Governors Board at Boston College Ceo Club. In the future, he will be an Independent Director at CVS Health Corp. He has previously held positions as the Chief Executive Officer at IntElect Medical, Inc., President & Chief Executive Officer at Global Healthcare Exchange LLC, Chief Executive Officer at IoGyn, Inc., Worldwide Group Chairman at DePuy Orthopaedics, Inc., Chairman-Worldwide Medical Devices & Diagnostics at Johnson & Johnson, and President at Corvita Corp. and Lumenis, Inc. He has also served as a Director at Advanced Medical Technology Association, Baxter Healthcare Pty Ltd., Baxter SpA, VisionBank of Iowa, Baxter Healthcare Ltd. (United Kingdom), AdvaMed Accel, VisionBankshares, Inc., Boys & Girls Club of Boston, and GE Medical Systems, Inc. Mr. Mahoney holds an MBA from Wake Forest University and an undergraduate degree from the University of Iowa. |
| Kenneth Stein |
Kenneth Stein is currently the Global Chief Medical Officer & Senior VP at Boston Scientific Corp. He previously worked as the Director-Clinical Cardiac Electrophysiology at Weill Cornell Medical Center. Before that, he was an Associate Professor at Cornell University from 1994 to 2009. Dr. Stein completed his undergraduate degree at Harvard College. |
| Vance Ronald Brown |
Vance Ronald Brown is currently serving as the Secretary, Director & Vice President at EndoChoice Holdings, Inc. He is also the Secretary & Director at BTG Ltd. Additionally, he holds positions as Secretary & Director at Lumenis, Inc., Boston Scientific Ltd., and Biocompatibles UK Ltd. He is the Co-Managing Director at Boston Scientific Medizintechnik GmbH. In the future, he will serve as the Director, Secretary, VP & General Counsel at Apollo Endosurgery, Inc. Previously, he held positions as Co-Managing Director at StarMedTec GmbH and as an Attorney at Skadden, Arps, Slate, Meagher & Flom LLP. Mr. Brown obtained his undergraduate degree from the University of Western Ontario and his graduate degree from Harvard Law School. |
| Daniel J. Brennan |
Daniel J. Brennan is an Independent Director at Waters Corp. since 2022 and at Boston Scientific Corp. since 1996, where he previously served as the Chief Financial Officer & Executive Vice President starting in 2013. He was also an Independent Director at Nuance Communications, Inc. from 2018 to 2022. Mr. Brennan holds an undergraduate degree and an MBA from Babson College. |
| Jodi Eddy |
Jodi Eddy is an Independent Director at Adient plc since 2023. Prior to this, Mr. Eddy was the Chief Information & Digital Officer, Senior VP at Boston Scientific Corp. since 2013. Mr. Eddy previously worked at GE Aerospace as the Chief Information Officer-Oil & Gas Business from 2008 to 2013. Mr. Eddy completed their undergraduate degree at Southern Connecticut State University. |
| Susan J. Thompson |
Susan J. Thompson currently works at Boston Scientific Corp., as Chief Corporate Counsel, VP & Assistant Secretary from 2022. |
| Mary Beth Moynihan |
Mary Beth Moynihan is an Independent Director at Vapotherm, Inc. since 2021. She is also a Director at Medexecwomen since 2018. Previously, she served as the Chief Marketing Officer & Senior VP-Market Access at Boston Scientific Corp. from 1997 to the present. Prior to that, she worked as an Auditor & Financial Analyst at Digital Equipment Corp. from 1989 to 1992. Ms. Moynihan completed her undergraduate degree at Williams College and holds an MBA from The Wharton School of the University of Pennsylvania. |
| Jonathan Richard Monson |
Jonathan Richard Monson has held various director positions in multiple companies, including Boston Scientific Korea Holding Co. Ltd., BTG Ltd., Lumenis, Inc., Boston Scientific International SA, Boston Scientific Ltd., Biocompatibles UK Ltd., Apollo Endosurgery, Inc., and Bravo Bidco Ltd. He also served as the Chief Executive Officer of Boston Scientific Korea Holding Co. Ltd. and as the Senior Vice President-Investor Relations at Boston Scientific Corp. |
| Emily Woodworth |
Emily Woodworth currently works at Boston Scientific Corp., as Chief Accounting Officer, SVP & Group Controller from 2024. |
| John Bradley Sorenson |
John Bradley Sorenson is currently the Executive Vice President-Global Operations at Boston Scientific Corp. He previously worked as the President & Chief Operating Officer at QRS Diagnostic LLC. He completed his undergraduate degree at Gustavus Adolphus College and holds an MBA from the University of Minnesota. |
| June Chang |
June Chang is currently a Non-Executive Director at Acotec Scientific Holdings Ltd. and President-Greater China at Boston Scientific Corp. She is also a Member of The Chartered Institute of Management Accountants. Ms. Chang received a graduate degree from Thunderbird School of Global Management in 2001 and an undergraduate degree from Foster School of Business in 1997. |
| Samuel Conaway |
Samuel Conaway is an Independent Director at Fractyl Health, Inc. He is also a Director at JINGDONG Property, Inc., JD Palatine LLC, International Andreas Gruentzig Society, and President-US Sales Cardiology Group at Boston Scientific Corp. Previously, he worked as a Vice President at Abbott Vascular, Inc. Mr. Conaway holds an MBA from the University of Maryland and an undergraduate degree from the University of Phoenix. |
| Joseph M. Fitzgerald |
Joseph M. Fitzgerald is currently the President-Interventional Cardiology & Executive VP at Boston Scientific Corp. He previously worked as the Director-Business Intelligence at Anheuser Busch, Inc., the President at CryoCor, Inc., and the Vice President-Global Marketing at NeuroVascular Recovery Ltd. Mr. Fitzgerald completed his undergraduate degree at Indiana University and holds an MBA from Southern Illinois University. |
| Eric Francis Yves Thepaut |
Eric Francis Yves Thepaut is currently working as a Director at Boston Scientific International SA. He also holds the position of EVP, President-Europe, Middle East & Africa at Boston Scientific Corp. since 2020. Mr. Thepaut has an MBA from Université Paris Dauphine-PSL. |
| David Scott Wichmann |
David Scott Wichmann's current jobs include being an Independent Director at Boston Scientific Corp., a Director at the Minnesota Orchestral Association, a Director at the Council for Affordable Quality Healthcare, Inc., a Director at Vytalize Health, Inc., and an Independent Director at Privia Health Group, Inc. Mr. Wichmann's former jobs include being the Chief Executive Officer & Director at UnitedHealth Group, Inc. from 2017 to 2021, the Chief Executive Officer-Specialized Care Services at OptumHealth, Inc. from 2004 to 2013, an Independent Director at Tennant Co., a Partner at Arthur Andersen LLP from 1995 to 1998, the CFO, President-Operations & Technology at UnitedHealthcare, Inc. in 2006, and the Chief Financial Officer at Advance Machine Co. from 1994 to 1994. Mr. Wichmann obtained his undergraduate degree from Illinois State University. |
| Charles J. Dockendorff |
Charles J. Dockendorff is currently an Independent Director at Hologic, Inc., Boston Scientific Corp., Haemonetics Corp., Keysight Technologies, Inc., and Management Sciences for Health, Inc. He previously held positions as a Director at Somanetics Corp. and Aspect Medical Systems, Inc. He also worked as an Accountant at General Motors Corp. and Ernst & Young LLP. Additionally, he served as a Principal at ev3, Inc. and held the role of Chief Financial Officer & Executive Vice President at Covidien LP, Covidien New Zealand Ltd., and Covidien Unlimited Co. He was also a Controller at Kendall Healthcare Products and held various financial positions at Epsco, Inc. and Infrared Industries, Inc. Mr. Dockendorff received a graduate degree from Bentley University and an undergraduate degree from the University of Massachusetts. |
| Yoshiaki Fujimori |
Yoshiaki Fujimori is currently the Chairman at Oracle Corp Japan, Novapar SA, and serves as an Independent Director at Boston Scientific Corp., Shiseido Co., Ltd., and Takeda Pharmaceutical Co., Ltd. He is also the Representative Director at GraceA, Inc. and a Trustee at Carnegie Mellon University. Additionally, he holds the position of Senior Adviser at CVC Asia Pacific (Japan) KK. In his former roles, Mr. Fujimori served as the President, Chief Executive Officer & Director at LIXIL Corp. from 2011 to 2016. He was also the President & Chief Executive Officer at GE Medical Systems, Inc., GE Plastics, and General Electric Japan Corp. He held the position of President & Chief Executive Officer at GE Money Asia and President, CEO & Representative Director at LIXIL Corp. He served as an Independent Director at Tokyo Electric Power Co. Holdings, Inc. and TOSHIBA Corp. He was an Outside Director at HITOWA Holdings Co. Ltd. and a Director at Japan Construction Material & Housing Equipment Industries Fed. He also held senior positions at GE Aerospace and General Electric Co.Mr. Fujimori's education includes an MBA from Carnegie Mellon University, an undergraduate degree from the University of Tokyo, and an undergraduate degree from Tokyo University of Science. |
| Ellen M. Zane |
Ellen M. Zane is currently the President & Chief Executive Officer at The Floating Hospital, Inc. and Tufts Medical Center, Inc. She is also the Independent Chairman at Haemonetics Corp. Additionally, she holds the position of Vice Chairman at George Washington University. In her former roles, she served as the Chief Executive Officer at Quincy Hospital and the President & Chief Executive Officer at Floating Hospital For Children. She was also the Chairman at Massachusetts Health & Hospital Association, Inc. and an Independent Director at Lincare Holdings, Inc. and Azenta, Inc. Furthermore, she currently holds positions as an Independent Director at Haemonetics Corp., Director at PAREXEL International Corp., and Assistant Professor at Tufts University School of Medicine. Dr. Zane received her undergraduate degree from George Washington University in 1973 and her graduate degree from The Catholic University of America in 1975. |
| John Edward Sununu |
John Edward Sununu is currently an Independent Director at Boston Scientific Corp., a Director at ConvergEx, Inc., a Director at Juliet Marine Systems, Inc., a Director at Afiniti Ltd. (Bermuda), an Independent Director at BlueRiver Acquisition Corp., a Director at Sorenson Communications LLC, a Director & Council member at Lloyd's of London Ltd., and a Council Member at The Society of Lloyd's. Previously, Mr. Sununu served as an Independent Director at Time Warner Cable, Inc. from 2009 to 2016. He was also a Director at Melinta Subsidiary Corp. and Afiniti, Inc. Additionally, he was a Member of the U.S. House of Representatives from 1996 to 2002 and served as the Chief Financial Officer at Teletrol Systems, Inc. from 1993 to 1996. Mr. Sununu obtained his undergraduate degree from Massachusetts Institute of Technology. He also holds a graduate degree from Massachusetts Institute of Technology, which was conferred in 1987. Furthermore, he earned an MBA from Harvard Business School in 1991. |
| Susan E. Morano |
Susan E. Morano is an Independent Director at Boston Scientific Corp. She previously worked as a Director of Clinical Operations at Cutanea Life Sciences, Inc. and as a Senior Manager of Medical Affairs at Fibrocell Science, Inc. She also held the position of Manager of Scientific Communications at Dermik Laboratories, Inc. Ms. Morano's most recent former position was as the VP of Business Development and Strategic Operations at Johnson & Johnson. She completed her undergraduate degree at Villanova University and earned an MBA from Columbia Business School. |
| Jessica L. Mega |
Jessica L. Mega is the founder of Verily Life Sciences LLC, a company founded in 2015. She held the title of Chief Medical & Scientific Officer from 2015 to 2023. Currently, Dr. Mega is an Independent Director at Danaher Corp. since 2019 and at Boston Scientific Corp. since 2023. In terms of education, Dr. Mega completed her undergraduate degree at Stanford University in 1996. She also obtained a graduate degree from Harvard T.H. Chan School of Public Health and a doctorate from Yale School of Medicine. |
